REGENERON4U Trademark

Trademark Overview

On Monday, May 23, 2011, a trademark application was filed for REGENERON4U with the United States Patent and Trademark Office. The USPTO has given the REGENERON4U trademark a serial number of 85327089. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 30, 2013. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON4U trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services
regeneron4u

General Information

Serial Number85327089
Word MarkREGENERON4U
Filing DateMonday, May 23, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 30, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2011

Trademark Statements

Goods and Servicesproviding medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services
Pseudo MarkREGENERON FOUR YOU; REGENERON FOR YOU

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 26, 2011
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, December 30, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 30, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2013EXTENSION 3 GRANTED
Wednesday, May 29, 2013EXTENSION 3 FILED
Wednesday, May 29, 2013TEAS EXTENSION RECEIVED
Saturday, December 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 30, 2012EXTENSION 2 GRANTED
Tuesday, November 27, 2012EXTENSION 2 FILED
Wednesday, November 28, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 27, 2012TEAS EXTENSION RECEIVED
Tuesday, May 29, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 25, 2012EXTENSION 1 GRANTED
Friday, May 25, 2012EXTENSION 1 FILED
Friday, May 25, 2012TEAS EXTENSION RECEIVED
Tuesday, November 29, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 31, 2011ASSIGNED TO LIE
Thursday, August 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 17, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 17, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 3, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2011NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2011NON-FINAL ACTION WRITTEN
Monday, August 1, 2011ASSIGNED TO EXAMINER
Friday, May 27, 2011NOTICE OF PSEUDO MARK MAILED
Thursday, May 26, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 26, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

regeneron medical information public general consumers regarding products services patients pharmaceutical